Pamela J. Fink

powered by
COS Expertise®
University of Washington
School of Medicine
Immunology
ProfessorAppointed: 1990

Mailing Address

University of Washington
Department of Immunology
Box 357650
HSB I607H
Seattle, Washington 98195
United States

Contact Information

Phone: (206) 685-3608
Fax: (206) 221-5433
pfink@u.washington.edu

Qualifications

Assistant Member, Scripps Research Institute, 1990.
Postdoctoral Training, University of California, San Diego, 1988.
Postdoctoral Training, Stanford University, 1983.
Ph.D., Massachusetts Institute of Technology, Biology, 1981.

Expertise and Research Interests

T cells recognize foreign peptide antigens in the context of cell surface molecules encoded by the major histocompatibility complex. The T cell receptor (TCR) that mediates this specific recognition is a heterodimer consisting of alpha and beta chains. Both of these chains are encoded by separate gene elements that undergo rearrangement somatically, during the course of T cell differentiation within the thymus.

Work in Dr. Fink's laboratory centers around a transgenic line of mice that carries a rearranged Vß5+TCR ß chain gene in its genome. The alpha chains expressed by the T cells in these transgenic mice are encoded by endogenous genes that must undergo somatic rearrangement. These mice have been used to study the induction of self tolerance among mature peripheral T cells. An age-dependent deletion of populations of transgenic T cells is one result of encounter with a tolerogen that induces both phenotypic and functional changes in reactive T cells prior to their deletion. T cells in these animals also begin rearranging endogenous TCR ß chain genes, overcoming the barrier of TCR ß chain allelic exclusion. This process is called TCR revision, and results in a population of functional, self tolerant T cells expressing a diverse TCR repertoire. Current work focuses on the function of post-revision T cells.

Additional research in the lab centers on a novel function for Fas ligand, well known for its ability to deliver death signals through its receptor Fas. Fas ligand can also deliver a costimulatory signal inward, thereby enhancing antigen-specific proliferation of the Fas ligand expressing cell. FasL costimulation enhances antigen-specific proliferation and cytokine production and influences T cell maturation. Downstream mediators of signal transduction through Fas ligand have been defined, and the domains of the FasL molecule responsible for delivering this signal have been identified, and are distinct from those that induce death through Fas. We have also developed a method for tagging recent thymic emigrants in unmanipulated mice, and have discovered that RTEs undergo continued maturation in the lymphoid periphery. This maturation requires contact with secondary lymphoid organs. Future work is directed at determining whether RTEs can form long term memory and whether they are more prone to tolerance than are mature naive T cells.

Keywords

COS Keywords:

Blood Or Blood Products Or Transfusions, Bone Marrow Transplantation, Cell Biology, Genetics, Gerontology, Immunobiology, Immunology, Lymphocytes, Transgenic Animals, Transgenics.

Additional Terms:

Aging, Blood, Blood Cells, Bone Marrow Transplantation, Calcium in the Regulation of Tissue, Cell Function, Cellular, Genetic Approaches, Gerontology, Hematopoiesis, Immunobiology, Immunology, Lymphocytes, Lymphopoie, White Cells.

Memberships

American Association of Immunologists
Phi Beta Kappa

Previous Positions

1996-2004, Associate Professor, University of Washington, School of Medicine, Immunology
1990-1996, Assistant Professor, University of Washington, School of Medicine, Immunology
1988-1990, Assistant Member, Scripps Clinic and Research Foundation, Immunology
1987-1987, Bonner Instructor, University of California, San Diego, Biology/Cancer Center
1984-1987, Assistant Research Biologist, University of California, San Diego

Publications

  • P.J.Fink (2006) T cells Stop to Smell the (Antigenic)Roses, Journal of Immunology, 177, 1379
  • P.J. Fink (2006) T cells join the Blimp-1 Brigade, Nature Immunology, 7, 445
  • J.S. Hale, T.E. Boursalian, G.L. Turk, P.J. Fink (2006) Thymic Output in Aged Mice, Proceedings of the National Academy of Science, USA, 103, 8447-8452
  • M. Sun, K.T. Ames, I. Suzuki, P.J. Fink (2006) The Cytoplasmic Domain of Fas Ligand Costimulates TCR Signals, Journal of Immunology, 177, 1481
  • Boursalian T.E., Golob J., Soper D.M., Cooper C.J., Fink P.J., Continued Maturation of Thymic Emigrants in the Periphery, Nature Immunology, 5, 418-425, 2004
  • Cooper C.J., Turk G.L., Sun M., Farr A.G., Fink P.J., Cutting Edge: TCR Revision Occurs in Germinal Centers, Journal of Immunology, 173, 6532-6536, 2004
  • Cooper C.J., Orr M.T., McMahan C.J., Fink P.J., T Cell Receptor Revision Does Not Solely Target Recent Thymic Emigrants, Journal of Immunology, 171, 226-233, 2003
  • Boursalian, T.E., Fink, P.J., Mutation in Fas Ligand Impairs Maturation of Thymocytes Bearing Moderate Affinity T Cell Receptors, Journal of Experimental Medicine, 198, 349-360, 2003
  • Ali M., Weinreich M., Balcaitis S., Cooper C.J., Fink P.J., Differential Regulation of Peripheral CD4+ T Cell Tolerance Induced By Deletion and TCR Revision, Journal of Immunology, 171, 6290-6296, 2003
  • McMahan CJ, Fink PJ, Receptor revision in peripheral T cells creates a diverse V beta repertoire, Journal of Immunology, 165(12), 6902-7, 2000 Abstract
  • Suzuki I, Martin S, Boursalian TE, Beers C, Fink PJ, Fas ligand costimulates the in vivo proliferation of CD8+ T cells, Journal of Immunology, 165(10), 5537-43, 2000 Abstract
  • Fink PJ, McMahan CJ, Lymphocytes rearrange, edit and revise their antigen receptors to be useful yet safe, Immunology Today, 21(11), 561-6, November 2000 Abstract
  • Suzuki I, Fink PJ, The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells, Proceedings of the National Academy of Sciences (USA), 97(4), 1707-12, 2000 Abstract
  • McMahan, C.J. and P.J. Fink, RAG reexpression and DNA recombination at T cell receptor loci in peripheral CD4+ T cells, Immunity, 9, 637-647, November 1998
  • Suzuki I, Fink P J, Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand., Journal of Experimental Medicine, 187(1), 123-8, 5 Jan 1998 Abstract

Profile Details

Last Updated: 6/19/2007

COS Expertise ID #307473
Reference this profile directly: http://myprofile.cos.com/finkp73